Phase 2 trial of pembrolizumab plus SurVaxM for patients with glioblastoma at first recurrence (RESURGe)
Publication Date
6-2-2024
Presented At:
American Society of Clinical Oncology (ASCO) Annual Meeting
Citation
Ahluwalia, Manmeet and Ozair, Ahmad, "Phase 2 trial of pembrolizumab plus SurVaxM for patients with glioblastoma at first recurrence (RESURGe)" (2024). All Publications. 5479.
https://scholarlycommons.baptisthealth.net/se-all-publications/5479